25 June 2016

Hydrodec targets USA

Robert Tyerman

Recycled transformer oil pioneer Hydrodec plans a £15 million push into the USA, after winning approvals and orders in Australia.

Mark McNamara, chief executive officer of AIM-quoted Hydrodec, described approvals won from the State of Victoria’s two largest electricity distributors for the company’s “Superfine” transformer oil – made from “degraded” waste oil – as a ‘watershed’. A large South Australian utility has also approved Superfine, which recently won a 22p-a-litre federal subsidy under the Australian Oil Product Stewardship programme.

Chaired by long-term backer John Gunn, the former City tycoon who now supports early-stage and often green-tinged ventures, Hydrodec is in line for ‘three big contracts’ that will take half the capacity of its one operating plant in Young, New South Wales, according to McNamara.

He claimed the company should now be able to grab 30 per cent of Australia’s transformer oil market, where transformer maker Schneider Electric has already agreed to use Superfine.

McNamara said all this could take Hydrodec into profitability in the second half of this year, after cutting its losses in 2006 from nearly £6 million to £2.8 million. But the big prize is the US market, where Hydrodec can present Superfine as green – in that it uses up waste oil – as well as being cheap and reducing American dependence on imported oil.

The company has received planning permission for a plant in Ohio and plans a second facility in Mississippi. McNamara said Ohio should start producing in late 2008, with Mississippi on stream early the following year.

The cost would be around £15 million and McNamara suggested there is an offer of a debt and convertible finance package on the table from a major US corporation. A third facility on the West coast of the USA might be considered later on.

‘Hydrodec will grow tenfold in 24 months,’ boasted McNamara. The company, which eschews joint ventures in a bid to guard its patented intellectual property, reckons it has many other uses besides transformer oil.

Floated at 5p in 2004, Hydrodec shares reached 37.5p in March last year, but now trade at 26p, down 0.5p this morning and valuing the company at £48 million. If the orders do come and the financing offers come through, they could find new favour.

Cash Shells 2015

Published in September 2015 this annual research report provides a comprehensive overview of cash shells on the Main Market, AIM and PLUS landscape. Order your copy today

 

Superb investment toolkit for private investors

SharePad is the new web-based service from ShareScope. Easier to use and more powerful. Perfect for tablets, Macs and Windows PC. Covers ALL your investment requirements.

Growth Company Investor: free trial

Since 2008, our share tips outperformed the benchmark by 281%. Take a free trial and get access to our recommendations today. Start free trial now.

Directors' Pay on AIM 2015

The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1000+ AIM-quoted companies. The full report is available to order for £385 + VAT. Click here for more info

 

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

Stadium hit by profit warning

Stadium Group shares have been hit by a profit warning. This is a particular blow given the company’s progress in repositioning itself into a higher quality, design-led business.

Verona raises £42m to fund drug trials 

Verona Pharma (AIM: VRP) has raised an impressive £42 million net of costs which will fund phase II trials for its RPL554 compound. This drug targets severe respiratory diseases, in particular the 65 million worldwide sufferers from COPD (chronic obstructive pulmonary disease).

Income attractions at Belvoir

It’s fair to say that buy-to-let landlords have been under George Osborne’s cosh. He’s introduced a raised stamp duty rate and withdrawn higher-rate tax relief. However, Belvoir Lettings has seen little change in the market as far as its core lettings agency business is concerned. Furthermore, the shares have responded positively to a major acquisition which makes Belvoir the largest UK lettings agent.

Wincanton keeps on trucking

Wincanton CEO Adrian Colman feels his company is now back on an even keel after a period of fire-fighting. Debt has been brought under control, the pension deficit is being addressed, and onerous leases and contracts have been dealt with. A return to the dividend list illustrates these positive changes and the fact that management can now fully focus on growing the business.

VP maintains its reputation for quality  

Plant hire company VP continues to perform well against a mixed backdrop. Management said that the core infrastructure, housing and construction markets remained generally supportive and have offset weakness in oil and gas.

Redhall on the road back to profitability 

Redhall's interim results show the turnround at this specialist engineer is on track. The growth in the order book is particularly encouraging and lends credibility to forecasts of a significant return to profitability over the next couple of years.

More News